1. Stevenson DD, White AA. Clinical characteristics of aspirinexacerbated respiratory disease. Immunol Allergy Clin N Am. 2016;36:643-55.

2. Yoo H-S, Shin Y-S, Liu LN, Kim M-A, Park H-S. Clinical significance of immunoglobulin E responses to staphylococcal superantigens in patients with aspirin-exacerbated respiratory disease. Int Arch Allergy Immunol. 2013;162:340-5.

3. Rodríguez-Jiménez JC, Moreno-Paz FJ, Terán LM, Guaní-Guerra E. Aspirin exacerbated respiratory disease: Current topics and trends. Respir Med. 2018;135:62-75.

4. Woessner KM. Update on aspirin-exacerbated respiratory disease. Curr Allergy Asthma Rep. 2017;17(1):2.

5. Andrade MC, Pacheco RR, Almeida M, Takejima P, Aun MV, Kalil J, et al. Avaliação do fenótipo atópico nos pacientes com DREA. Arq Asma Alerg Imunol. 2018;2(2):253-7.